Island Pharmaceuticals LtdASX: ILA

IRB approval received for ISLA101 Phase 2a clinical trial

Dec 15, 2022 at 3:28 AM UTC · Issued by Island Pharmaceuticals Ltd

Island Pharmaceuticals Ltd has released a press release.

View Attachment